Millennium Management’s BeOne Medicines Ltd ONC Stock Holding History

Millennium Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,000	Closed	-$6.08M	–	6538
2025 Q4	$6.08M	Sell	20,000 -30,000	-60%	-$9.82M	﹤0.01%	2797
2025 Q3	$17M	Buy	+50,000	New	+$15.2M	0.01%	1836
2023 Q4	–	Sell	-23,800	Closed	-$4.28M	–	6637
2023 Q3	$4.28M	Buy	+23,800	New	+$4.71M	﹤0.01%	2836
2022 Q2	–	Sell	-16,000	Closed	-$3.02M	–	7608
2022 Q1	$3.02M	Buy	16,000 +6,000	+60%	+$1.28M	﹤0.01%	3492
2021 Q4	$2.71M	Buy	+10,000	New	+$3.38M	﹤0.01%	3489
2020 Q2	–	Sell	-50,000	Closed	-$6.16M	–	4681
2020 Q1	$6.16M	Buy	+50,000	New	+$7.82M	0.01%	1177
2019 Q4	–	Sell	-50,000	Closed	-$6.12M	–	4699
2019 Q3	$6.12M	Buy	+50,000	New	+$6.64M	0.01%	1645
2019 Q2	–	Sell	-21,900	Closed	-$2.89M	–	4547
2019 Q1	$2.89M	Buy	+21,900	New	+$2.95M	﹤0.01%	2155
2018 Q2	–	Sell	-20,000	Closed	-$3.36M	–	4253
2018 Q1	$3.36M	Buy	+20,000	New	+$2.71M	﹤0.01%	2033

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Millennium Management's ONC Position: Q1 2026 in Review

Millennium Management increased its BeOne Medicines Ltd (ONC) stake by 551% in Q1 2026, buying an estimated $56.1M and bringing the position to 204,846 shares worth $60.8M. The position accounts for 0.03% of the portfolio, ranked #712.

Millennium Management first reported a position in ONC in Q1 2016 and has held it in 31 quarters since. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

Millennium Management held 204,846 shares of BeOne Medicines Ltd worth $60.8M as of Q1 2026.
Millennium Management bought 173,395 BeOne Medicines Ltd shares in Q1 2026, an estimated $56.1M.
BeOne Medicines Ltd made up 0.03% of Millennium Management's portfolio in Q1 2026, its #712 holding.
Millennium Management first reported a position in BeOne Medicines Ltd in Q1 2016 and has held it in 31 quarters since.
281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.